Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02249390 · ClinicalTrials.gov registry record
Assisted Reproductive Technology Survey (ART Survey)
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 336
- Enrollment target
NCT02249390: Completed study, sponsored by Pennington Biomedical Research Center.
NCT02249390 is a clinical trial that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 336 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02249390 has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 336 participants
- Enrollment target
Study Summary
The purpose of the study is to collate local information to better understand the motivations, accessibility and frequency of assisted reproductive technology (ART) use in the community.
Primary Outcome
ART Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 336 participants |
| Start Date | 2014-09 |
| Est. Completion | 2017-04 |
What the finished NCT02249390 record still lists
NCT02249390 is an observational study that tracks outcomes without assigning an intervention. The registered 336 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02249390 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02249390 about?
NCT02249390 is a clinical study titled "Assisted Reproductive Technology Survey (ART Survey)". The purpose of the study is to collate local information to better understand the motivations, accessibility and frequency of assisted reproductive technology (ART) use in the community.
What is the current status of trial NCT02249390?
This trial is currently completed. The enrollment target is 336 participants. The study started on 2014-09. Estimated completion is 2017-04.
Who is sponsoring clinical trial NCT02249390?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03947385 · 336 participants · Phase 1
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
- NCT03977207 · 336 participants · NA
A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients
- NCT04665206 · 336 participants · Phase 1
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
- NCT05124457 · 336 participants · Phase 2
DETERMINE: Detemir vs NPH
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia